MOXIFLOXACIN HCL MOXIFLOXACIN HCL MOXIFLOXACIN HCL MOXIFLOXACIN HCL MOXIFLOXACIN HCL MOXIFLOXACIN HCL
MOXIFLOXACIN HCL
MOXIFLOXACIN HCL MOXIFLOXACIN HCL MOXIFLOXACIN HCL MOXIFLOXACIN HCL MOXIFLOXACIN HCL

MOXIFLOXACIN HCL

Product Details:

  • Heavy Metal (%) NA
  • Shelf Life 3 Years
  • Smell Other
  • HS Code 30049039
  • Molecular Formula C21H24FN3O4HCl
  • Ph Level 1.26.8
  • Particle Size 0.6 to 8.0 m
  • Click to View more
X

MOXIFLOXACIN HCL Price And Quantity

  • 5 Kilograms

MOXIFLOXACIN HCL Product Specifications

  • Other
  • yellow to yellow crystalline powder or solid
  • Other
  • 30049039
  • 3 Years
  • Moxifloxacin HCL is one type of antibiotic. Moxifloxacin HCL belongs to the class called fluoroquinolone. Moxifloxacin HCL gives antibiotic activity by killing the bacteria. Moxifloxacin HCL used in the treatment of pneumonia, tuberculosis, conjunctivitis.
  • NA
  • C21H24FN3O4HCl
  • moderate solubility in water, with a solubility of approximately 2.9 mg/mL at 25C
  • MOXIFLOXACIN HCL
  • C21H24FN3O4HCl
  • 636C
  • 238-250C
  • 1.26.8
  • 99%
  • 186826-86-8
  • 0.6 to 8.0 m
  • 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride
  • Room Temperature
  • Powder
  • Industrial Grade
  • Other
  • NA
  • 437.89 Grams (g)

MOXIFLOXACIN HCL Trade Information

  • NHAVA SHEVA
  • Cash Advance (CA), Cheque
  • 100 Kilograms Per Week
  • 1 Days
  • No
  • HDPE DRUM WITH TWO INNER LDPE LINER
  • Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
  • All India
  • WHO GMP,GMP,GLP,ISO

Product Description

NiksanPharmaceutical is world’s leadingmanufacturer, trader, exporter and supplier of the Moxifloxacin HCL API and Moxifloxacin HCL formulations. Niksan Pharmaceuticalmanufactures large quantity of Moxifloxacin HCL API and finished products inAnkleshwar, Gujarat, India. Niksan Pharmaceutical and Niksan group companiesare the largest manufacturers and suppliers of Moxifloxacin HCL products.

 

NiksanPharmaceutical exporting very bigquantity of the fine quality products of Moxifloxacin HCL in all overworld for many years in a countries like Canada, USA, Romania, Finland,Malaysia, Netherland, South Africa, Brazil, Egypt, Singapore, Jordan, Lebanon,Israel, Vietnam, Bangladesh, Paraguay, Argentina, Dominican Republic, Sudan,Hong Kong, Seychelles, Algeria, Iran, Uruguay, Russia, Thailand, Afghanistan,Latvia, Lithuania, UnitedArab Emirates, Seychelles, Peru, Switzerland, Tunisia, France, Hungary,Finland, Turkey, Pakistan, Rwanda, South Africa, Denmark, Malawi, Croatia,Slovenia, Ireland, Zambia, Cyprus, Nigeria, Uzbekistan, Cameroon, Netherlands,Azerbaijan, Venezuela, Morocco, Cote Ivories, Lucia, South Korea, Congo,Philippines, Colombia Sweden, Hungary, Mauritius, Vanuatu, Malta, Kazakistan,Slovenia, Bolivia, Japan, Uganda, Australia and many more countries.

 

NiksanPharmaceutical also supplieslarge quantity of MoxifloxacinHCL products in Indian stateslike Gujarat, Haryana, Rajasthan, Madhya Pradesh, Kerala, Tamilnadu, Delhi,Bihar, Uttar Pradesh, Assam, Goa, Hyderabad, Telangana, Mizoram, Sikkim etc.

 

MoxifloxacinHCL is one type ofantibiotic. Moxifloxacin HCL belongs to the class called fluoroquinolone.Moxifloxacin HCL gives antibiotic activity by killing the bacteria.Moxifloxacin HCL used in the treatment of pneumonia, tuberculosis, conjunctivitis. Moxifloxacin HCL available in tablet, creams, ointments and capsules.

 

SYNONYMS: Moxifloxacin HCL, Moxifloxacino HCL

 

IUPACNAME: 1-Cyclopropyl-6-fluoro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydro-3-quinolinecarboxylicacid hydrochloride

 

CAS NO: 12-8039

 

MOLECULAR FORMULA: C21H25ClFN3O4

 

MOLECULAT MASS: 437.89 G/MOL

 

STORAGE CONDITIONS: Store in cool and dry place, away from direct sun light and heat. Donot store medicine in bathroom or any humid place. Keep away from children andpets.

HOW TO USE: Take medicine orally with or without food once per day. Wash eyes andremove the lance before using Moxifloxacinophthalmic solution. Do not consume the ophthalmic solution. Take your doctor’sadvice if you have any confusion related to the medicine.

 

HOW MOXIFLOXACINHCL WORKS: Moxifloxacin inhibits thetopoisomerase II and topoisomerase IV enzyme. By inhibiting these enzymesMoxifloxacin inhibits the replication of DNA. And also inhibits the celldivision of the bacteria.

 

PHARMACOKINETICS: Moxifloxacin absorbed rapidly after oraladministration having bioavaibility of 90%. Almost 50% of drug binds withplasma proteins. Half-life of Moxifloxacin is between 11.5-15.6 hours.Approximately 45% of Moxifloxacin drug eliminated through urination and faces.

 

SIDE EFFECTSOF MOXIFLOXACIN: The common side effectsof Moxifloxacin are nausea, vomiting, headache, insomnia, weakness, dizzinessare seen in patients. If you see signs of kidney problem, liver problem, GIproblem like bleeding, stomach pain, abdominal discomfort, dark urine seekimmediate medical attention. Moxifloxacin also cause some intestinal problemlike bloody stool, abdominal pain, diarrhoea, cramping in intestine.

PRECAUTION: Tell your doctor if you have allergic reaction toMoxifloxacin medicine. If you have problem like liver problem, heart problem,depression, brain problem like Alzheimer’s, blood vessels problem, mooddisorders, brain tumours, or any blood pressure problem tell your doctor beforetaking the medication. Moxifloxacin can increase the heart problems so kindlyavoid the medicine if you have any heart related problems.

 

CDSCO APPROVAL: Moxifloxacin (0.5%) +Dexamethasone Phosphate (0.1%) Eye dropsapproved by CDSCO in India in 24.11.2005,

Moxifloxacin HCL (0.5%) +Ketorolac Tromethamine 0.5% Ophthalmic Solution approved by CDSCO in India in11.07.2007,

Moxifloxacin tab. approvedby CDSCO in India in 27.12.2001,

Difluprednate 0.05% w/v +Moxifloxacin 0.5% w/v Eye Drops app rovedby CDSCO in India in 22.09.2011

Moxifloxacin intravenousinfusion approved by CDSCO in India in 13.02.2002

Moxifloxacin HCl (5mg) +Prednisolone Acetate (10mg) per ml. (eyedro ps) approved by CDSCO in India in16.10.2007

Ketorolac Tromethamine 0.4%w/v + Moxifloxacin 0.5% w/v ophthalmicsol ution approved by CDSCO in India in 21.09.2010

Loteprednol etabonate 0.5%w/v + Moxifloxacin 0.5% w/v ophthalmic Suspension approved by CDSCO in India in01.12.2009

Moxifloxacin ophthalmicsolution approved by CDSCO in India in 19.10.2007

Moxifloxacin eye ointmentapproved by CDSCO in India in 01.10.2008

Moxifloxacin HCl approvedby CDSCO in India in 06.06.2001

Moxifloxacin HCl BP 0.5%w/v + Bromfenac Sodium 0.09% w/v Eye drop approved by CDSCO in India in05.01.2011

Moxifloxacin ophthalmicsolution 0.5% approved by CDSCO in India in 27.08.2004

Moxifloxacin Eye Ointment(5mg/gm) approved by CDSCO in India in 06.02.2006

Cefixime (SR) 400mg +Moxifloxacin (SR) 400 mg Tablets approved by CDSCO in India in 08.08.2011

 

FORMULATIONS AVAILABLE INMARKET:

Moxifloxacin (0.5%) +Dexamethasone Phosphate (0.1%) Eye drops

Moxifloxacin HCL (0.5%) +Ketorolac Tromethamine 0.5% OphthalmicSolution

Moxifloxacin tablets

Difluprednate 0.05% w/v +Moxifloxacin 0.5% w/v Eye Drops

Moxifloxacin intravenousinfusion

Moxifloxacin HCl (5mg) +Prednisolone Acetate (10mg) per ml. (eyedrops)

Ketorolac Tromethamine 0.4%w/v + Moxifloxacin 0.5% w/v ophthalmicsolution

Loteprednol etabonate 0.5%w/v + Moxifloxacin 0.5% w/v ophthalmicSuspension

Moxifloxacin HCl BP 0.5%w/v + Bromfenac Sodium 0.09% w/v Eye drop

Moxifloxacin Eye Ointment(5mg/gm)

Cefixime (SR) 400mg +Moxifloxacin (SR) 400 mg Tablets

 

Note: Product protected by valid patents are not offered for sale incountries where such patents are still valid and its liability is at BuyersRisk.

 

REFERENCES:

www.webmd.com

https://pubchem.ncbi.nlm.nih.gov

https://go.drugbank.com

https://cdscoonline.gov.in

https://www.wikipedia.org/

https://www.drugs.com

https://www.zaubacorp.com

https://www.practo.com/consult

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Active Pharmaceuticals Ingredients (API)' category



trade india member
NIKSAN PHARMACEUTICAL All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.